ื›ื•ืจื›ื•ืžื™ืŸ + ืคื™ืคืจื™ืŸ - ื”ืฆืžื“ ืฉืžื“ืข ืžื•ื“ืจื ื™ ืžืืฉืจ ื›ื ื•ื’ื“ ื“ืœืงืช | ื”ืžื“ืจื™ืš ื”ืžืœื

ืžื—ืงืจื™ื ืืœื• ืžื™ื•ื“ืขื™ื ืœืฉื™ืžื•ืฉ ืžื™ื“ืข ื‘ืœื‘ื“ ื•ืื™ื ื ืžื”ื•ื•ื™ื ืชื—ืœื™ืฃ ืœื™ื•ืขืฅ ืจืคื•ืื™.
ืื ื• ืžืกืคืงื™ื ืžื™ื“ืข ื–ื” ื›ืฉื™ืจื•ืช, ืื™ืŸ ืœื”ืžืœื™ืฅ ืื• ืœืืฉืจ ืžื•ืฆืจื™ื ืžื•ืฆืจื™ื ืขืœ ืคื™ ื–ื”.

ย 

ื”ืจื›ื™ื‘ ื”ืคืขื™ืœ ื‘ื›ื•ืจื›ื•ื ืฉื ื—ืงืจ ื‘ื™ื•ืชืจ ื‘ืขื•ืœื - ื•ืœืžื” ื‘ืœื™ ืคื™ืคืจื™ืŸ ื”ื•ื ืœื ืฉื•ื•ื” ื”ืจื‘ื”

ื‘ืงืฆืจื”: ื›ื•ืจื›ื•ืžื™ืŸ ื”ื•ื ื”ืคื•ืœื™ืคื ื•ืœ ื”ืคืขื™ืœ ื‘ื›ื•ืจื›ื•ื ืขื ืคืขื™ืœื•ืช ื ื•ื’ื“ืช ื“ืœืงืช ื•ื ื•ื’ื“ืช ื—ืžืฆื•ืŸ ืžื•ื›ื—ืช. ื”ื‘ืขื™ื” - ืกืคื™ื’ืชื• ื’ืจื•ืขื”. ืคื™ืคืจื™ืŸ 5 ืž"ื’ ืžื’ื“ื™ืœ ืืช ื”ืกืคื™ื’ื” ื‘ืฆื•ืจื” ื“ืจืžื˜ื™ืช. ืžื˜ื”-ืื ืœื™ื–ื” ืฉืœ 13 RCTs ืžืืฉืจืช: ื”ืฉื™ืœื•ื‘ ืžืคื—ื™ืช TNF-alpha, IL-6 ื•-MDA ื‘ืฆื•ืจื” ืžื•ื‘ื”ืงืช.

ื›ื•ืจื›ื•ืžื™ืŸ - ื”ืจื›ื™ื‘ ื”ื ื—ืงืจ ื‘ื™ื•ืชืจ ื‘ืขื•ืœื ื”ืฆืžื—ื™

ื›ื•ืจื›ื•ืžื™ืŸ (Curcumin) ื”ื•ื ืคื•ืœื™ืคื ื•ืœ ื”ืฉื™ื™ืš ืœืžืฉืคื—ืช ื”ื›ื•ืจื›ื•ืžื™ื ื•ืื™ื“ื™ื, ื”ืžื•ืคืง ืžืฉื•ืจืฉ ื”ื›ื•ืจื›ื•ื (Curcuma longa). ื”ื•ื ืžืฉืžืฉ ื‘ืจืคื•ืื” ื”ืžืกื•ืจืชื™ืช ื”ื”ื•ื“ื™ืช (ืื™ื•ืจื•ื•ื“ื”) ืœืžืขืœื” ืž-4,000 ืฉื ื” ื•ื ื—ืงืจ ื‘-ื™ื•ืชืจ ืž-1000 ืžื—ืงืจื™ื ืžื“ืขื™ื™ื.

ื”ืจื›ื™ื‘ื™ื ื”ืคืขื™ืœื™ื - ื›ื•ืจื›ื•ืžื™ื ื•ืื™ื“ื™ื - ื›ื•ืœืœื™ื:

  • Curcumin - ื”ืจื›ื™ื‘ ื”ืขื™ืงืจื™ (ื›-75% ืžื”ื›ื•ืจื›ื•ืžื™ื ื•ืื™ื“ื™ื)
  • Bisdemethoxycurcumin - ืชื•ืจื ืœืคืขื™ืœื•ืช ื ื•ื’ื“ืช ื”ื—ืžืฆื•ืŸ
  • Demethoxycurcumin - ืคื•ืขืœ ื‘ืกื™ื ืจื’ื™ื” ืขื ื›ื•ืจื›ื•ืžื™ืŸ

ื”ืืชื’ืจ: ืกืคื™ื’ื” ื’ืจื•ืขื”

ื”ื‘ืขื™ื” ื”ืžืจื›ื–ื™ืช ื‘ื›ื•ืจื›ื•ืžื™ืŸ: ื‘ื™ื•-ื–ืžื™ื ื•ืช ื ืžื•ื›ื” ืžืื•ื“. ื”ื’ื•ืฃ ืžืคืจืง ื•ืžื—ืกืœ ืื•ืชื• ื‘ืžื”ื™ืจื•ืช ืœืคื ื™ ืฉืžืกืคื™ืง ืœื”ื™ืกืคื’. ืจื™ื›ื•ื– ื”ื›ื•ืจื›ื•ืžื™ืŸ ื‘ื“ื ืœืื—ืจ ื ื˜ื™ืœื” ืจื’ื™ืœื” ื”ื•ื ื–ื ื™ื—.

ื”ืคืชืจื•ืŸ ืฉื”ืžื“ืข ืžืืฉืจ: ืคื™ืคืจื™ืŸ.

ืคื™ืคืจื™ืŸ - ืžื’ื‘ืจ ื”ืกืคื™ื’ื” ื”ื˜ื‘ืขื™

ืคื™ืคืจื™ืŸ (Piperine) ื”ื•ื ื”ืจื›ื™ื‘ ื”ืคืขื™ืœ ื‘ืคืœืคืœ ืฉื—ื•ืจ. ืžื ื’ื ื•ืŸ ื”ืคืขื•ืœื”:

  • ืžืขื›ื‘ ืืช ืื ื–ื™ื CYP3A4 ืฉืžืคืจืง ื›ื•ืจื›ื•ืžื™ืŸ ื‘ื›ื‘ื“
  • ืžืื™ื˜ ืืช ืคื™ื ื•ื™ ื”ื›ื•ืจื›ื•ืžื™ืŸ ืžื”ื’ื•ืฃ
  • ืžื’ื“ื™ืœ ืืช ื–ืžืŸ ื”ืฉื”ื•ืช ื‘ื“ื

๐Ÿ”ฌ Thanawala et al., 2024 (Alternative Therapies - PMID: 38702159)

ืžื—ืงืจ ืคืจืžืงื•ืงื™ื ื˜ื™ ื”ืฉื•ื•ืืชื™ ื‘ื™ืŸ ื›ื•ืจื›ื•ืžื™ืŸ+ืคื™ืคืจื™ืŸ ืœืขื•ืžืช ืชืฆื•ืจื” ืื—ืจืช. ื›ื•ืจื›ื•ืžื™ืŸ+ืคื™ืคืจื™ืŸ ื”ืจืื” Cmax ืฉืœ 22.75 ng/mL ืœืขื•ืžืช ืจื™ื›ื•ื–ื™ื ื ืžื•ื›ื™ื ื‘ืฆื•ืจื•ืช ืกืคื™ื’ื” ืื—ืจื•ืช, ืขื AUC ืฉืœ 359.86 h-ng/mL.

PubMed PMID: 38702159

ืžื” ื”ืžื—ืงืจื™ื ืื•ืžืจื™ื ืขืœ ืคืขื™ืœื•ืช ื ื•ื’ื“ืช ื”ื“ืœืงืช?

๐Ÿ”ฌ Hosseini et al., 2025 - ืžื˜ื”-ืื ืœื™ื–ื” ืฉืœ 13 RCTs (PMID: 38561618)

ื”ืžื—ืงืจ ื”ื’ื“ื•ืœ ื•ื”ืžืฉืžืขื•ืชื™ ื‘ื™ื•ืชืจ: ืžื˜ื”-ืื ืœื™ื–ื” ืฉืกื™ื›ืžื” 13 ื ื™ืกื•ื™ื™ื ืงืœื™ื ื™ื™ื ืžื‘ื•ืงืจื™ื ืขืœ ื›ื•ืจื›ื•ืžื™ืŸ+ืคื™ืคืจื™ืŸ. ืชื•ืฆืื•ืช:

  • ื™ืจื™ื“ื” ื‘-TNF-alpha - ืฆื™ื˜ื•ืงื™ืŸ ื“ืœืงืชื™ ืžืจื›ื–ื™
  • ื™ืจื™ื“ื” ื‘-IL-6 - ืกืžืŸ ื“ืœืงืช ื—ืฉื•ื‘
  • ื™ืจื™ื“ื” ื‘-MDA - ืžื“ื“ ืœื ื–ืง ื—ืžืฆื•ื ื™
  • ืขืœื™ื™ื” ื‘-SOD ื•-GSH - ื ื•ื’ื“ื™ ื—ืžืฆื•ืŸ ืคื ื™ืžื™ื™ื

PubMed PMID: 38561618

ื”ืฉื•ื•ืื”: ื›ื•ืจื›ื•ืžื™ืŸ 95% ืžื•ืœ ื›ื•ืจื›ื•ื ืจื’ื™ืœ

ืžื•ืฆืจ ืจื™ื›ื•ื– ื›ื•ืจื›ื•ืžื™ืŸ ืกืคื™ื’ื”
ื›ื•ืจื›ื•ื ืฉื•ืจืฉ ื˜ืจื™ 2-5% ื ืžื•ื›ื” ืžืื•ื“
ืื‘ืงืช ื›ื•ืจื›ื•ื 3-5% ื ืžื•ื›ื”
ื›ื•ืจื›ื•ืžื™ืŸ 95% (ืœืœื ืคื™ืคืจื™ืŸ) 95% ื‘ื™ื ื•ื ื™ืช
ื›ื•ืจื›ื•ืžื™ืŸ 95% + ืคื™ืคืจื™ืŸ 5 ืž"ื’ 95% ื’ื‘ื•ื”ื”

ืžื™ ืขืฉื•ื™ ืœื”ืคื™ืง ืชื•ืขืœืช?

  • ๐Ÿฆด ืื ืฉื™ื ืขื ืื™-ื ื•ื—ื•ืช ื‘ืžืคืจืงื™ื - ื›ื•ืจื›ื•ืžื™ืŸ ื ื—ืงืจ ื‘ื”ืงืฉืจ ืฉืœ ืชืžื™ื›ื” ื‘ื‘ืจื™ืื•ืช ื”ืžืคืจืงื™ื
  • ๐Ÿ‹๏ธ ืกืคื•ืจื˜ืื™ื - ื ื—ืงืจ ื‘ื”ืงืฉืจ ืฉืœ ืชืžื™ื›ื” ื‘ื”ื—ืœืžื” ืœืื—ืจ ืื™ืžื•ืŸ
  • ๐Ÿ›ก๏ธ ืžื™ ืฉืžื—ืคืฉ ืชืžื™ื›ื” ื ื•ื’ื“ืช ื—ืžืฆื•ืŸ - ื ื—ืงืจ ื‘ื”ืงืฉืจ ืฉืœ ื”ื’ื ื” ืขืœ ืชืื™ื ืžื ื–ืง ื—ืžืฆื•ื ื™
  • ๐ŸŒฟ ืžื™ ืฉืžืขื“ื™ืฃ ืชืžื™ื›ื” ื˜ื‘ืขื™ืช - ืœืฆื“ ืื•ืจื— ื—ื™ื™ื ื‘ืจื™ื
ืฉื™ื ืœื‘: ื›ื•ืจื›ื•ืžื™ืŸ ืขืฉื•ื™ ืœื“ืœืœ ื“ื ื•ืœื”ืฉืคื™ืข ืขืœ ืชืจื•ืคื•ืช ืžืกื•ื™ืžื•ืช. ืžื™ ื”ื ื•ื˜ืœ ื ื•ื’ื“ื™ ืงืจื™ืฉื” - ืžื•ืžืœืฅ ืœื”ืชื™ื™ืขืฅ ืขื ืจื•ืคื ืœืคื ื™ ื ื˜ื™ืœื”.

* ื”ืžื™ื“ืข ื‘ืืชืจ ื–ื” ื”ื•ื ืœืžื˜ืจื•ืช ืžื™ื“ืข ื‘ืœื‘ื“ ื•ืื™ื ื• ืžื”ื•ื•ื” ื™ื™ืขื•ืฅ ืจืคื•ืื™. ืชื•ืกืคื™ ืชื–ื•ื ื” ืื™ื ื ืชืจื•ืคื•ืช ื•ืื™ื ื ืžื™ื•ืขื“ื™ื ืœืื‘ื—ืŸ, ืœืจืคื ืื• ืœืžื ื•ืข ืžื—ืœื”.